News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Jones Michael L
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/21/2022 |
4
| Jones Michael L (Exec. Director, Finance - PAO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 5,900 shares
@ $0
Granted 8,500 options to buy
@ $10.63, valued at
$90.4k
|
|
| 12/19/2022 |
4
| Jones Michael L (Exec. Director, Finance - PAO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 445 shares
@ $10.9, valued at
$4.9k
|
|
| 12/02/2022 |
4
| Jones Michael L (Exec. Director, Finance - PAO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 8,600 shares
@ $13.01, valued at
$111.9k
Exercised 8,600 options to buy
@ $1.42, valued at
$12.2k
|
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2021 |
4
| Jones Michael L (Exec. Director, Finance - PAO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Exercised 4,500 options to buy
@ $3.51, valued at
$15.8k
|
|
| 12/17/2020 |
4
| Jones Michael L (Exec. Director, Finance - PAO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $8.31, valued at
$249.3k
|
|
| 12/07/2020 |
4
| Jones Michael L (Exec. Director, Finance - PAO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 5,000 options to buy
@ $5.45, valued at
$27.3k
|
|
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|